Brief: Cleveland Biolabs Gets Nasdaq Extension To Regain Compliance With Listing Rule
04/05/2020 13:58
May 4 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS - ON MAY 1, NASDAQ HEARINGS PANEL
GRANTED CO
FURTHER EXTENSION TO AUG 17 IN WHICH TO REGAIN COMPLIANCE WITH
NASDAQ LISTING RULE
Source text: https://bit.ly/2WnJfC1
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc